Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418 — Providence, Rhode Island

Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418 is a clinical research site located in Providence, Rhode Island, United States 02903-4923.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418 has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma (MM), Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418?

Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418 conducted?

Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418 has 1 clinical trials on record. Their work covers Multiple Myeloma (MM), Cancer.

Is Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418 accredited by Crixeo Health?

Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lifespan Cancer Institute at Rhode Island Hospital /ID# 215418?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.